Cleared Traditional

K102433 - MOORVMS-PRES PRESSURE CUFF CONTROLLER

K102433 is the FDA 510(k) clearance for MOORVMS-PRES PRESSURE CUFF CONTROLLER by Moor Instruments, Ltd.. It is a Class 2 Cardiovascular device (product code DPW) cleared through the Traditional 510(k) pathway after a 84-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2010
Decision
84d
Days
Class 2
Risk

K102433 is an FDA 510(k) clearance for the MOORVMS-PRES PRESSURE CUFF CONTROLLER. Classified as Flowmeter, Blood, Cardiovascular (product code DPW), Class II - Special Controls.

Submitted by Moor Instruments, Ltd. (Axminster, Devon, GB). The FDA issued a Cleared decision on November 18, 2010 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2100 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Moor Instruments, Ltd. devices

Submission Details

510(k) Number K102433 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 26, 2010
Decision Date November 18, 2010
Days to Decision 84 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 125d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DPW Flowmeter, Blood, Cardiovascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPW Flowmeter, Blood, Cardiovascular

All 32
Devices cleared under the same product code (DPW) and FDA review panel - the closest regulatory comparables to K102433.
FlowMet-R
K182494 · Laser Associated Sciences, Inc. · Feb 2019
iCertainty
K181269 · Rfpi · Dec 2018
Deltex Medical CardioQ-EDM+, Deltex Medical CardioQ-EDM
K172457 · Deltex Medical Limited · Jun 2018
MONITOR, MODEL HSM-00200
K031153 · Arrow Intl., Inc. · Nov 2003
CAPIOX CARDIOTOMY RESERVOIR
K030505 · Terumo Cardiovascular Systems Corp. · May 2003
MS DISPOSABLE RIGID DOPPLER PROBE
K930227 · Meadox Medicals, Div. Boston Scientific Corp. · Sep 1993